You are here: Home » News-IANS » Diaspora
Business Standard

Cancer treatment breakthrough by Indian American professor

IANS  |  New York 

Queen's University researcher Koti has discovered a biomarker that will help lead to better predictions of the success of chemotherapy in ovarian patients.

Biomarkers are an indicator of a biological state or condition, and the discovery could lead to better treatment options in the fight against ovarian cancer, according to a press release from the university.

"Recent successes in harnessing the immune system to combat are evidence for the significant roles of a patient's immune responses in fighting cancer," explains Indian American professor Dr. Koti.

"Many of these successes are based on boosting anti-immunity via different therapies. Such therapies would prove to be most effective when coupled with markers predicting a patient's eventual response to a specific therapy".

Dr. Koti's study, conducted on over 200 ovarian patients, utilised a combination of cutting-edge detection technologies for identifying such markers.

A major impact of this discovery is that these novel markers, when used at the time of treatment initiation in the specific type of ovarian patient, will help oncologists make decisions on additional treatment needed in these patients, thus increasing their potential for survival.

Ovarian leads to approximately 152,000 deaths among women worldwide each year, making it a leading cause of gynaecological related deaths in women.

RECOMMENDED FOR YOU